Ac-MBP 1-11, a short peptide sequence, is the major encephalitogenic epitope in myelin basic protein (MBP).
Ac-MBP 1-11, or Acetylated Myelin Basic Protein fragment 1-11, is a synthetic peptide corresponding to the N-terminal residues of myelin basic protein with an acetyl modification. As a well-characterized immunodominant epitope, this peptide is widely recognized for its central role in neuroimmunological research, particularly in the study of demyelinating diseases and autoimmune responses. Its defined sequence and post-translational modification make it a valuable tool for dissecting antigenic specificity, T cell recognition, and the molecular mechanisms underlying neuroinflammation. The fragment's biochemical relevance extends to investigations of peptide-MHC interactions and the pathophysiology of central nervous system disorders.
Immunological assay development: Ac-MBP 1-11 serves as a critical reagent in the establishment and optimization of immunological assays, such as ELISPOT, proliferation assays, and cytokine release measurements. By providing a defined antigenic stimulus, the peptide enables precise evaluation of T cell responses, particularly in models of neuroautoimmunity. Its use supports the characterization of antigen-specific lymphocyte populations, facilitating studies on immune cell activation, tolerance, and the dynamics of autoantigen recognition.
Autoimmunity modeling: As a representative epitope of myelin basic protein, this peptide is extensively employed in experimental autoimmune encephalomyelitis (EAE) models, a widely used animal model for multiple sclerosis research. The synthetic fragment is utilized to induce and monitor disease progression, allowing researchers to investigate mechanisms of T cell-mediated demyelination, neuroinflammation, and the efficacy of novel immunomodulatory strategies. Its application provides a controlled platform for dissecting the immunopathogenesis of central nervous system autoimmunity.
Epitope mapping and antigen presentation studies: The defined sequence of Ac-MBP 1-11 makes it an ideal substrate for epitope mapping and analysis of peptide-MHC binding. Researchers employ the peptide to delineate the minimal antigenic determinants required for T cell recognition, assess binding affinities to various MHC class II molecules, and study the structural requirements for antigen processing and presentation. These insights are instrumental in understanding the molecular basis of antigen specificity and the development of immune tolerance or autoimmunity.
Peptide-MHC complex structural analysis: The acetylated MBP 1-11 peptide is frequently used in structural biology to generate stable peptide-MHC complexes for crystallographic and biophysical studies. By enabling the formation of homogeneous complexes, it supports high-resolution analyses of T cell receptor recognition, MHC binding pockets, and the conformational dynamics underlying immune recognition. Such studies contribute to the rational design of immunotherapies and the elucidation of autoimmune disease mechanisms.
Peptide synthesis and modification research: As a model system, Ac-MBP 1-11 is utilized to explore synthetic strategies for peptide production, post-translational modifications, and stability optimization. Researchers leverage its well-defined sequence to refine solid-phase peptide synthesis protocols, investigate the effects of N-terminal acetylation on peptide conformation and function, and develop analytical methods for peptide characterization. These efforts advance the broader field of peptide chemistry and support the development of novel biomolecular tools for immunological research.
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More